Announce Date | 08/05/2025 |
EPS Normalized Actual | $0.08 (Beat by $0.14) |
EPS GAAP Actual | $0.08 (Beat by $0.14) |
Revenue Actual | $8.66156B |
Revenue Surprise | Beat by $8661.56M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.29 |
EPS GAAP Estimate | $0.29 |
Revenue Estimate | $15.03B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 2.04 | 14.57 | 1.70179 | 2.34747 | 1 |
Dec 2026 | -1.61 | -18.46 | -1.86361 | -1.20593 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.1 | 0.1 | 8.66156B | 100% | -4767.55M |
FQ1 2025 (Mar 2025) | -2.36 | -2.36 | 12.9762B | 100% | 12976.2M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | 1.01 | 1.01 | 0B | NAN% | 0M |
FQ2 2024 (Jun 2024) | -0.4 | -0.4 | 0B | NAN% | 0M |
FQ3 2024 (Sep 2024) | -0.13 | -0.13 | 0B | NAN% | 0M |
FQ4 2024 (Dec 2024) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.29
Consensus Revenue Estimates
15.03B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Dec 2025) | -0.36 | -- | -0.87 | 0.02 | 6 |
FQ3 2025 (Sep 2025) | 0.29 | 144.83 | -0.02 | 0.74 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Dec 2025) | 12.07B | -- | 10.97B | 12.73B | 6 |
FQ3 2025 (Sep 2025) | 15.03B | -- | 10.41B | 18.97B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
3
EPS # of in-lines
2
Revenue # of Beats
1
Revenue # of Misses
1
Revenue # of in-lines
5
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | 0.1 | 0.1 | 100% |
FQ1 2025 (Mar 2025) | -2.36 | -2.36 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 1.01 | 1.01 | 100% | |
FQ2 2024 (Jun 2024) | -0.4 | -0.4 | 100% | |
FQ3 2024 (Sep 2024) | -0.13 | -0.13 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $13.43B | $8.66B | $-4767.55M | -55.04% |
FQ1 2025 (Mar 2025) | $0B | $12.98B | $12976.2M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |